Inventor · Beijing, CN

Lin Kang

14Patents
4h-index
34Co-inventors
56Inventor score

Filing activity: Aug 6, 2008 → Sep 12, 2024

Most-cited inventions

PatentTitleAreaCited byStatus
US8263065B2 Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells Human Necessities 23 Active
US8926964B2 Methods of generating natural killer cells Emerging Cross-Sectional Technologies 17 Active
US9464274B2 Methods of generating natural killer cells Emerging Cross-Sectional Technologies 7 Active
US9255248B2 Method of producing erythrocytes without feeder cells Chemistry; Metallurgy 5 Active
US9216200B2 Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells Human Necessities 3 Active
US8586360B2 Method of producing erythrocytes without feeder cells Chemistry; Metallurgy 3 Active
US9200253B1 Method of producing erythrocytes Chemistry; Metallurgy 3 Active
US11971486B2 Method for generating three-dimensional images with superconducting nanowire photon detection array Electricity 1 Active
US10846324B2 Device, method, and user interface for managing and interacting with media content Physics 0 Active
US9763983B2 Natural killer cells from placenta Chemistry; Metallurgy 0 Active
US11180731B2 Methods of treating acute myeloid leukemia and multiple myeloma using natural killer cells Chemistry; Metallurgy 0 Active
US10041043B2 Method of producing erythrocytes without feeder cells Chemistry; Metallurgy 0 Active
US12282025B1 Rapid detection method for ricin toxin Physics 0 Active
US12360116B2 Rapid detection method for abrin toxin Emerging Cross-Sectional Technologies 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.